Product Description
A tVNS instrument consisting of two titan electrodes mounted on a gel frame and connected to a wired neurostimulating device (CM02, Cerbomed, Erlangen, Germany) was used.
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Guangdong Provincial Hospital of Chinese Medicine
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
ChiCTR-IOR-17012238 |
ChiCTR-IOR-17012238 | N/A |
Recruiting |
Psoriasis |
2020-04-01 |
|||
ChiCTR1800019905 |
ChiCTR1800019905 | N/A |
Recruiting |
Psoriasis |
2019-12-31 |
|||
ChiCTR-IOR-17011075 |
ChiCTR-IOR-17011075 | N/A |
Not yet recruiting |
Psoriasis |
2017-12-30 |
|||
ChiCTR-IOR-15006768 |
ChiCTR-IOR-15006768 | N/A |
Recruiting |
Psoriasis |
2017-06-30 |
|||
NCT01178437 |
cMPsE01 | N/A |
Completed |
Epilepsy |
2010-09-01 |
2019-03-19 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
05/15/2024 |
PubMed |
Design and Biological Evaluation of the Long-Acting C5-Inhibited Ornithodoros moubata Complement Inhibitor (OmCI) Modified with Fatty Acid. |
|
11/14/2023 |
News Article |
Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023 |
|
09/20/2023 |
News Article |
GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference |
|
04/07/2023 |
PubMed |
Deciphering the mechanism of PSORI-CM02 in suppressing keratinocyte proliferation through the mTOR/HK2/glycolysis axis. |
|
10/11/2022 |
News Article |
GeoVax to Present at Vaccines Summit-2022 |
|
10/06/2022 |
News Article |
GeoVax to Present at Upcoming Investor Conferences |
|
04/30/2021 |
PubMed |
Anti-Angiogenic Efficacy of PSORI-CM02 and the Associated Mechanism in Psoriasis In Vitro and In Vivo. |